BSE filing, NSE: NEXUSCOMMO. Summary written from the filing by ALFA Finder's alert engine.
Nexus Surgical and Medicare Ltd: key numbers
- Share price
- ₹21.48
- Market cap
- ₹11.75 Cr
- Revenue (annual)
- ₹7.87 Cr
- Net profit (annual)
- ₹0.74 Cr
- P/E (TTM)
- 14.9×Sector 36.4×
- Promoter holding
- 18.73%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nexus Surgical and Medicare Ltd
All →Nexus Surgical and Medicare Management Change
Shareholders approved the appointment of Mr. Anish More as Managing Director of Nexus Surgical and Medicare for a three-year term, effective September 2, 2026.
- Execution
- 3 years
Nexus Surgical and Medicare Annual General Meeting
Nexus Surgical And Medicare Limited held its 35th Annual General Meeting on September 25, 2026. Shareholders discussed and voted on routine agenda items.
Nexus Surgical and Medicare Price Movement Clarification
Nexus Surgical and Medicare Ltd clarified that recent stock price movements are purely market-driven, confirming no undisclosed information or pending corporate actions exist.
Nexus Surgical and Medicare Annual Report
Nexus Surgical and Medicare Limited filed its Annual Report and AGM Notice for the financial year 2025-26. The document details company performance and upcoming director appointments.
Nexus Surgical and Medicare Annual General Meeting
Nexus Surgical and Medicare Limited has scheduled its 35th Annual General Meeting for September 25, 2026, via video conferencing. The register of members will close accordingly.
Nexus Surgical and Medicare Other Announcement
Nexus Surgical and Medicare reconstituted its Audit, Nomination & Remuneration, and Stakeholders Relationship committees. These changes were effective from September 2, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.